Iscador Qu for chronic hepatitis C: an exploratory study

Author(s): Spoek, J., Kramers, C.

Abstract: Five patients with chronic hepatitis C were treated for one year with the herbal immunomodulatory agent Iscador (Weleda, Schwäbisch Gmünd Germany).Two patients showed 6-20 fold decreases in viral load and normalisation of liver inflammation.The treatment was well tolerated; no serious side effects were observed. The quality of life improved an average. Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.

Zurück | Weiter